(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

LIPOSANA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

LIPOSANA

ST13

US500000097363473

Class

5

Filing

97363473

Registration

7422748

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

38

Latest update

06/18/2024

Trademark type

Word

Nice classes

5

Filing date

04/14/2022

Registration date

06/18/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/18/2024

Last transaction

06/18/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

08/08/2023

First use in commerce

08/08/2023

Drawing code

4

Owner type

03

Owner location

Columbia, MD

Examiner

MCCARTHY, JOSEPH

Law office

N90

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Britecyte Inc.

Representatives

Scott D. Marty BALLARD SPAHR LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Human allograft tissue composed of lyophilized adipose for medical treatment of soft tissue defect

Publications

History of USPTO decisions and trademark events.

38 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

06/18/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

06/18/2024

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

05/10/2024

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

05/10/2024

XAEC

EXAMINER'S AMENDMENT ENTERED

05/10/2024

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

05/10/2024

GNEA

EXAMINERS AMENDMENT E-MAILED

05/10/2024

SNEA

SU-EXAMINER'S AMENDMENT WRITTEN

05/10/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

05/01/2024

GNRT

NON-FINAL ACTION E-MAILED

05/01/2024

CNRT

SU - NON-FINAL ACTION - WRITTEN

05/01/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/24/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/24/2024

ALIE

ASSIGNED TO LIE

04/24/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

12/05/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

12/01/2023

GNRT

NON-FINAL ACTION E-MAILED

12/01/2023

CNRT

SU - NON-FINAL ACTION - WRITTEN

12/01/2023

SUPC

STATEMENT OF USE PROCESSING COMPLETE

11/09/2023

IUAF

USE AMENDMENT FILED

10/12/2023

EISU

TEAS STATEMENT OF USE RECEIVED

10/12/2023

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

09/13/2023

INOA

AMENDMENT AFTER NOA NOT ENTERED

08/18/2023

EPPA

TEAS POST PUBLICATION AMENDMENT RECEIVED

08/18/2023

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

05/16/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/21/2023

PUBO

PUBLISHED FOR OPPOSITION

03/21/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/01/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/13/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/10/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/09/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

02/09/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

02/07/2023

GNRT

NON-FINAL ACTION E-MAILED

02/07/2023

CNRT

NON-FINAL ACTION WRITTEN

02/07/2023

DOCK

ASSIGNED TO EXAMINER

02/01/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/20/2022

NWAP

NEW APPLICATION ENTERED

04/18/2022

Continuous trademark protection

Get notified about every new filing that threatens LIPOSANA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.